Display options
Share it on

JACC Basic Transl Sci. 2016 Dec;1(7):617-629. doi: 10.1016/j.jacbts.2016.08.004.

Cardiac-Directed Expression of Adenylyl Cyclase Catalytic Domain Reverses Cardiac Dysfunction Caused by Sustained Beta-Adrenergic Receptor Stimulation.

JACC. Basic to translational science

Mei Hua Gao, N Chin Lai, Dimosthenis Giamouridis, Young Chul Kim, Zhen Tan, Tracy Guo, Wolfgang H Dillmann, Jorge Suarez, H Kirk Hammond

Affiliations

  1. VA San Diego Healthcare System and Department of Medicine, University of California San Diego.

PMID: 28670631 PMCID: PMC5490496 DOI: 10.1016/j.jacbts.2016.08.004

Abstract

OBJECTIVE: To test the hypothesis that cardiac-directed expression of the cytoplasmic domains of adenylyl cyclase-6 (AC6) would have beneficial effects on the heart.

BACKGROUND: Eliminating the two transmembrane domains of AC6 yields a protein with an intact catalytic domain that is disengaged from membrane-associated β-adrenergic receptor stimulation, but with enhanced propensity for intracellular interactions.

METHODS: We constructed a peptide of the C1 and C2 segments of AC6 (C1C2), expressed C1C2 in an adenovirus vector and generated transgenic lines with cardiac-directed C1C2 expression, which underwent sustained isoproterenol (Iso) infusion.

RESULTS: Gene transfer of C1C2 in cardiac myocytes showed reduced cAMP generation in response to Iso-stimulation. C1C2 transgenic mice had normal left ventricular (LV) structure and function. LV samples from C1C2 mice showed diminished Iso-stimulated cAMP generation but normal LV contractile responses, suggesting a compensatory mechanism. Cardiac myocytes from C1C2 mice showed increased Iso-stimulated Ca2+ release and reduced time to peak Ca2+ release. After 7 days Iso infusion, control mice tended to show reduced LV function, but C1C2 mice showed increases in both LV peak +dP/dt and peak -dP/dt indicating enhanced LV systolic and diastolic function. LV from C1C2 mice showed a 2.6-fold increase in SERCA2a protein, and cardiac myocytes showed increased Ca2+ release, reduced time to peak Ca2+ release and reduced Tau.

CONCLUSIONS: In C1C2 mice, sustained isoproterenol infusion increases rather than decreases LV function. Reduced cAMP generation and resistance to catecholamine cardiomyopathy are attractive features of this novel AC-related protein.

Keywords: cardiomyopathy; catecholamine; gene therapy; heart failure

References

  1. Am J Physiol Heart Circ Physiol. 2004 Nov;287(5):H1906-12 - PubMed
  2. Science. 1995 Jun 23;268(5218):1769-72 - PubMed
  3. Am J Physiol. 1997 Aug;273(2 Pt 2):H707-17 - PubMed
  4. J Biol Chem. 2008 Nov 28;283(48):33527-35 - PubMed
  5. Circulation. 2008 Jan 1;117(1):61-9 - PubMed
  6. J Biol Chem. 2004 Sep 10;279(37):38797-802 - PubMed
  7. Circulation. 1999 Mar 30;99(12):1618-22 - PubMed
  8. Circ Res. 1998 Dec 14-28;83(12):1205-14 - PubMed
  9. Circulation. 2004 Jul 20;110(3):330-6 - PubMed
  10. J Mol Cell Cardiol. 2013 Jul;60:60-7 - PubMed
  11. Circulation. 2002 Apr 23;105(16):1989-94 - PubMed
  12. Science. 2009 Sep 4;325(5945):1261-5 - PubMed
  13. Cell Signal. 2009 Feb;21(2):301-8 - PubMed
  14. Circulation. 1987 Dec;76(6):1422-36 - PubMed
  15. JAMA Cardiol. 2016 May 1;1(2):163-71 - PubMed
  16. J Am Coll Cardiol. 2011 May 3;57(18):1846-55 - PubMed
  17. Ann Thorac Surg. 2011 Jun;91(6):1907-13 - PubMed
  18. J Am Coll Cardiol. 2006 Aug 1;48(3):559-65 - PubMed
  19. Cell Signal. 2010 Apr;22(4):584-9 - PubMed
  20. Hum Gene Ther. 2013 Sep;24(9):777-85 - PubMed
  21. J Am Coll Cardiol. 2008 Apr 15;51(15):1490-7 - PubMed
  22. J Mol Cell Cardiol. 2006 Jul;41(1):170-81 - PubMed
  23. J Biol Chem. 1997 Aug 29;272(35):22265-71 - PubMed
  24. Circ Res. 2006 Jun 9;98 (11):1390-7 - PubMed
  25. Methods Mol Biol. 2007;357:271-96 - PubMed
  26. PLoS One. 2013 Sep 16;8(9):e72151 - PubMed
  27. Circulation. 2006 Aug 1;114(5):388-96 - PubMed

Publication Types

Grant support